Find My Journal

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp, Monika E. Hegi, Warren Mason, Martin J. van den Bent, Martin Taphoorn, Robert C. Janzer, Samuel K. Ludwin, Anouk Allgeier, Barbara Fisher, Karl Bélanger, Peter Hau, Alba A. Brandes, Johanna M. M. Gijtenbeek, Christine Marosi, Charles J. Vecht, Karima Mokhtari, Pieter Wesseling, S. Villà, Elizabeth A. Eisenhauer, Thierry Gorlia, Michael Weller, Denis Lacombe, J. Gregory Cairncross, René‐Olivier Mirimanoff

The Lancet Oncology, 2009

University Hospital of Lausanne, University of Lausanne, Princess Margaret Cancer Centre, University of Toronto, Erasmus University Rotterdam, University Medical Center Utrecht, Queen's University, European Organisation for Research and Treatment of Cancer, Western University, Hôpital Notre-Dame, Radboud University Medical Center, Radboud University Nijmegen, Medical University of Vienna, Sorbonne Université, Inserm, Institut Català d'Oncologia, Duran i Reynals Hospital, Ontario Institute for Cancer Research, University of Tübingen, University of Calgary

Publisher Website

Abstract

An abstract is not available for this record. Please visit the publisher website for more details.

7720

Citations

View on Google Scholar